Allergic reactions to seminal fluid are rare with only 40 cases reported worldwide. 1, 2 The features are typical of a type 1 hypersensitivity reaction with symptoms related to release of mast cell mediators resulting in localized swelling, itching or burning sensation occurring within minutes of exposure to an allergen and as they usually occur rapidly after coitus the association is readily made. The sensitizing antigen has been found in all human seminal fluid tested and as it is also present in prostatic tissue it is thought to be a poorly characterized glycoprotein produced by the prostate gland."
We report a case of a 26-year-old woman who experienced severe localized symptoms immediately after sexual intercourse due to a type 1 hypersensitivity reaction to a 100 kDa component of seminal plasma.
CASE REPORT
The patient was a 26-year-old woman who had been married for 2 years before the onset of symptoms and who had had no other sexual partners. There was no previous history of atopy, although her serum immunoglobulin E was elevated at 300 KU/L (normal 0-150 KU/L) and she had a class 2 positive radio-allergosorbent test to grass pollen (maximum class 4), but negative to a variety of common antigens including house dust, dust mite, penicillin, dog and cat dander. She developed symptoms of vulvo-vaginal pruritus and burning within minutes of unprotected intercourse which resolved over the following 1-2 h. When her husband used a condom intercourse was not associated with symptoms. Allergy to seminal plasma was 
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suspected and investigations were performed as described below.
Skin prick testing
The patient was skin prick tested against freshly obtained specimens of her husband's seminal fluid, seminal plasma and washed spermatazoa suspended in 0·9010 saline. A positive reaction of a wheal and flare was given to seminal fluid (wheal diameter 5 mm x 5 mm) and plasma (wheal diameter 5 mm x 5 mm) but not to spermatazoa or O:9% saline (negative control). Skin prick testing with seminal plasma after one freeze thaw cycle elicited only a weak response (wheal diameter 2 mm X 2 mm).
Characterization of antigen Molecular exclusion chromatography of seminal
plasma was performed on a 90 em column packed with Sephacryl S-3OO (Pharmacia Fine Chemicals Co., Uppsala, Sweden) equilibrated with O' 1 mol/L phosphate buffer pH 7' 4. The column was calibrated for molecular size using a standard range of molecular weight markers (Sigma Chemical Co., Poole, UK). A 1 mL sample of fresh seminal plasma was applied to the column and eluted with phosphate buffer at a flow rate of 12 mL/h. Fractions of 1 mL were collected and analysed for protein content by measuring absorbance at 280 nm and for immunoreactivity by skin prick testing. Significant reactivity was found in only fractions corresponding to a molecular weight of 100 kDa (Fig. 1 ).
Treatment
The patient was treated with a combination of intravaginal cromoglycate cream and oral antihistamines, both used 30 min prior to intercourse. This treatment failed to ameliorate her symptoms and her husband therefore continues to use condoms. plasma. For reasons of safety it was not possible to skin test her against fresh donor seminal plasma and therefore it is unclear whether this allergen is a universal component of seminal plasma. Previous reports have described an allergen of a lower molecular weight in the range 25-75 kDa present in all seminal plasma samples tested." Attempts to treat the patient with intravaginal cromoglycate cream in conjunction with precoital oral antihistamines unfortunately failed to alleviate her symptoms. Immunotherapy in cases of seminal plasma hypersensitivity has also been largely unsuccessful. The use of whole semen to desensitize patients risks severe anaphylactic reactions. The theoretical advantages of desensitization using purified protein fractions are that this risk might be reduced and the specificity of the response to the antigen heightened. In practice, however, it is not easy to prepare sufficient antigen to attempt this form of immunotherapy and even in the more successful reports it has proved difficult to maintain the desensitized state." Immunotherapy therefore was not used in this case and the patient was simply advised on the proper use of condoms to avoid contact with seminal fluid. If pregnancy is desired artifical insemination with washed spermatazoa will be considered. This patient exhibited a type 1 hypersensitivity reaction to a labile 100 kDa component of seminal plasma. Although allergy to exogenously derived antigens in seminal plasma such as walnut or penicillin has been described most cases are due to allergy to an endogenous component of seminal plasma.' While most women who develop an allergy to semen have a previous history of atopic disease the incidence of semen allergy is extremely rare even in atopic females, possibly due to immunosuppressive factors normally present in genital secretions. It has been proposed that events such as pregnancy, gynaecological surgery or vasectomy might affect immunosuppression in either the woman or her partner and reports of seminal allergy have occurred after events of this type.
Attempts to characterize further the 100 kDa antigenic component of seminal plasma were hindered by its marked lability and almost complete loss of immunoreactivity after a single freeze-thaw cycle. This may indicate that the offending antigen was one of the many protease enzymes which are present in seminal fluid, since these are easily denatured and rendered inactive by a freeze thaw cycle.
Our patient showed only a weak and transient reaction to HIV negative frozen donor seminal
